0389_hepatitis C virus, viral antibodies, quantitative [serum]

Standard Code (JLAC10)

1	Analyte	5F360	hepatitis C virus
	Identification	1492	viral antibodies, quantitative
	Specimen	023	serum
	Method	052	chemiluminescent enzyme immunoassay (CLEIA)
Result Identifying 01		00
Result Identifying 02		00

ISO15189 Applied Scope of Accreditation

RML00280 Basic Series (October 26, 2019 revised)
HCV antibody (Quantitative,Qualitative )
Medical Laboratory Accreditation Certificate
Japan Accreditation Board

Specimen

Top	Colour	Collected Sample	Quantity	Measured Material	Required
HotPink Top		blood	6 mL	serum

Specimen Rejection Criteria

haemolysis
clotted
lipaemia
inappropriate sample volume	reject
wrong container	reject
urine samples without the appropriate preservative
received ambient
unprotected from light
opening tubes
incterus

Specimen Stability Information

Specimen Type	Container	Temperature	Stability
serum		Refrigerated
		Frozen

Turnaround Time (TAT)

same day / 1 to 2 days

Laboratory

Central Laboratoryweekday (8:30 a.m. - 5:00 p.m.)
night time or weekend

Reference Value

Period / Age

		Male	Female
Specimen		blood
Method		chemiluminescent enzyme immunoassay (CLEIA)
00	cut-off index	< 1.0	< 1.0
00	judgement	negative	negative

		Male	Female	Unit
Specimen		blood
Method
00	hepatitis C virus, viral antibodies, quantitative	< 1.0	< 1.0	S/CO

		Male	Female	Unit
Specimen
Method

		Male	Female	Unit
Specimen
Method

		Male	Female	Unit
Specimen
Method

		Male	Female	Unit
Specimen
Method

		Male	Female	Unit
Specimen
Method

		Male	Female	Unit
Specimen
Method

Critical Value

High Value	Low Value

[0389 / 5F360] Japanese Ver.11 5.Immunological Test >> 5F.Virus Infection Test>>5F360 hepatitis C virus, viral antibodies, quantitative

hepatitis C virus, viral antibodies, quantitative

[serum]